From: The impact of serum copper on the risk of epilepsy: a mendelian randomization study
Exposure | Outcome | Methods | SNP (n) | Beta | P value |
---|---|---|---|---|---|
serum copper | Epilepsy (all documented cases) | MR Egger | 7 | 0.0738 | 0.2613 |
Weighted median | 0.0352 | 0.1482 | |||
Inverse variance weighted | 0.0402 | 0.0292 | |||
serum copper | Generalized epilepsy (all documented cases) | MR Egger | 7 | 0.2107 | 0.0835 |
Weighted median | 0.1129 | 0.0082 | |||
Inverse variance weighted | 0.0704 | 0.0316 | |||
serum copper | Focal epilepsy (all documented cases) | MR Egger | 8 | 0.0440 | 0.5906 |
Weighted median | 0.0315 | 0.2695 | |||
Inverse variance weighted | 0.0264 | 0.2454 |